CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to ...

RNA technology is credited with ending the COVID-19 pandemic But Department Secretary Robert F. Kennedy, Jr. says it's ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

HHS announced that it will no longer fund internal department research for mRNA vaccines for upper respiratory viruses like flu and COVID-19.

America's vaccine-sceptic health secretary has announced $500m (£375.8m) worth of cuts to their development in the country.

Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

The targeting of the vaccine technology once considered revolutionary follows intense criticism by conservatives and anti-vaccine activists.